Chemokinostatin-1

General Information


DRACP ID  DRACP02509

Peptide Name   Chemokinostatin-1

Sequence  NGRKACLNPASPIVKKIIEKMLNS

Sequence Length  24

UniProt ID  P09341 

PubChem CID  Not available

Origin  Homo sapiens (CXCL1/Gro-α)

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides Antiangiogenic



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  CXCR

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02509

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C114H202N34O32S2

Absent amino acids  DFHQTWY

Common amino acids  K

Mass  303562

Pl  10.8

Basic residues  5

Acidic residues  1

Hydrophobic residues  8

Net charge  4

Boman Index  -3382

Hydrophobicity  -25

Aliphatic Index  101.67

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18307172

Title  Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines

Doi 10.1002/jcb.21712

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.